Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
I. Holme,N. Cater,7 Authors,On Behalf Of The Incremental Decrease In End-Point
2008 · DOI: 10.1080/07853890801964955
Annals medicus · 59 Citations
TLDR
The on-treatment level of apoB/apoA-1 was the strongest predictor of MCE in the pooled patient population, whereas apo B and non-HDL-C were best able to explain the difference in outcome between treatment groups.